Boston, MA, May 16th, 2017 /PRNewswire/ — Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis expand their collaboration with Saama Technologies, Inc., the first advanced hybrid analytics company by developing reference solutions for Pharmacovigilance, Designed for Purpose Data Oceans and Application of Saama’s Fluid Analytics into Health Research modelling.
Elan Josielewski, Mapi’s VP of Strategy and Global Marketing, commented “We are innovating Health Research from the foundation, enabling our mutual customers to benefit from Mapi’s over 40 years in Patient-Centered research combined with Saama’s nearly 2 decades of data and analytics infrastructure expertise. The collaboration delivers efficient and effective use of technology to interpret and analyze real time data from international studies with higher data quality and speed than has previously been possible.”
Saama’s Fluid Analytics™ for Life Sciences delivers proven technology, methodology and services for rapidly orchestrating and analyzing large volumes of data. Their hybrid approach blends technology acceleration with human expertise and industry-specific data assets, enabling better business outcomes with speed and specificity. Now global pharmaceutical companies can make better clinical decisions before and after a product is introduced to the market, ultimately bringing safer, more effective products to patients in less time while enabling the platform to develop, synthesize and communicate evidence needed to meet the commercialization demands for Market access, Payer and Patient value communication.
Mapi and Saama are accelerating their collaborations through joint initiatives around Centralized Clinical Data Repository to accelerate the pace of clinical innovation; Automated publications and social media search for effective identification of adverse events to increase efficiency in Pharmacovigilance Operations; and Technology enabled services for Real-World Evidence generation, Health Research Analytics and Evidence Synthesis.
This comprehensive solution supports data integration, standardization, classification, text mining and sentiment analysis of various industry-specific data assets including social media and provides a query engine interface that will be utilized by Mapi experts to derive key patient insights.
Murali Krishnam, VP – Life Sciences Analytics Solutions, commented “Saama’s strategic partnership with Mapi will further strengthen our 20 years of creating analytics enabled business outcomes for our customers by combining our life sciences industry specific data analytics solutions and Mapi’s Patient-Centered research expertise. The combined assets will embed analytics directly within processes to provide real-time information and support guided clinical decisions for our mutual customers.”
Saama and Mapi will both be at the 2017 ISPOR conference in Boston during May 21stto the 25th. Come visit us at booth 919.
About Mapi: Patients are at the heart of our research
Mapi Group has over 40 years of experience supporting Life-Science companies in developing and implementing strategies for commercializing novel treatments through Strategic Regulatory Services, Pharmacovigilance, Market Access, Language Services, and gathering Real-World Evidence on Pharmaceuticals, Biologicals, and Medical Devices. Mapi Group is the premier provider of Health Research and Commercialization services to Life-Science companies enabling Market Authorization, Market Access and Market Adoption of novel therapeutics. Visit https://www.mapigroup.com for more information
Saama Technologies is the first advanced hybrid analytics company delivering actionable business insights for life sciences, and the Global 2000. We are singularly focused on driving fast, flexible, impactful business outcomes for our clients through data & analytics. Our unique “hybrid” approach integrates pre-packaged solutions and expertise across the life sciences domain, business consulting, data science, automated data management and big data technologies, blending manual and disconnected initiatives into a well-aligned roadmap facilitating the client’s journey from strategy through solution implementation.